Company news
Adc Therapeutics Sa (NYSE:ADCT) news
Every Adc Therapeutics Sa press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates
August 13, 2026
ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial
June 30, 2026
ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities
June 24, 2026
ADC Therapeutics Announces Results From LOTIS-5 Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in Relapse...
June 3, 2026
ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates
May 4, 2026
ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026
April 27, 2026
ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update
March 10, 2026
ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026
March 3, 2026
ADC Therapeutics to Participate in March Investor Conferences
February 24, 2026
ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement
February 23, 2026
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
February 2, 2026
ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates
January 8, 2026
ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 8, 2026
ADC Therapeutics Announces New Employee Inducement Grant
January 2, 2026
ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Support...
December 3, 2025
ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial
December 2, 2025
ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update
November 10, 2025
ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025
November 3, 2025
ADC Therapeutics to Present at November Investor Conferences
October 27, 2025
ADC Therapeutics Announces $60 Million Private Placement
October 13, 2025
ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025
August 27, 2025
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
August 12, 2025
ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025
August 5, 2025
ADC Therapeutics Makes Grant to New Employee Under Inducement Plan
July 1, 2025
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th Internatio...
June 16, 2025
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028
June 12, 2025
ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress
June 12, 2025
ADC Therapeutics to Present at Upcoming Investor Conferences
May 15, 2025
ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update
May 14, 2025
ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and...
May 14, 2025
ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025
May 8, 2025
ADC Therapeutics Announces Preclinical Data Highlighted at the American Association for Cancer Research Annual Meeting 2025
April 28, 2025
ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
April 1, 2025
ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update
March 27, 2025
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025
March 25, 2025
ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025
March 20, 2025